Evaluating the clinical utility of measuring levels of factor H and the related proteins

Evaluating the clinical utility of measuring levels of factor H and the related proteins

After years of disappointing clinical results, the tide has finally changed and complement targeted-therapies have become a validated and accepted treatment option for several diseases. These accomplishments have revitalized the field and brought renewed attention to the prospects that complement th...

Full description

Saved in:
Bibliographic Details
Main Authors: Banerjee, Pratiti, Veuskens, Bert, Goicoechea de Jorge, Elena, Józsi, Mihály, Baeumner, Antje J, Steiner, Mark-Steven, Pouw, Richard B, Toonen, Erik JM, Pauly, Diana, Poppelaars, Felix
Corporate Authors: Molecular Immunology (Issuing body), SciFiMed consortium (Issuing body)
Format: Article
Language:English
Published: Philipps-Universität Marburg 2022
Subjects:
Medizin
Complement system Factor H FHR FHL-1 Biomarker
Medical sciences Medicine
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

PDF Full Text

Holdings details from
Call Number: urn:nbn:de:hebis:04-es2024-07772
Publication Date: 2024-01-23
Source: Erstveröffentlichung: Banerjee P, Veuskens B, de Jorge EG, Józsi M, Baeumner AJ, Steiner MS, Pouw RB, Toonen EJM, Pauly D, Poppelaars F; SciFiMed Consortium. Evaluating the clinical utility of measuring levels of factor H and the related proteins. Mol Immunol. 2022 Nov;151:166-182. https://doi.org/10.1016/j.molimm.2022.08.010
Downloads: 71 (2024)
License: https://creativecommons.org/licenses/by/4.0
Access URL: https://archiv.ub.uni-marburg.de/es/2024/0777
https://doi.org/10.1016/j.molimm.2022.08.010

Similar Items